CERS - Cerus Corporation
Cerus Corporation Logo

CERS - Cerus Corporation

https://www.cerus.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.

52W High
$2.24
52W Low
$1.12
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.63
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-13.19
EV/Revenue (<3 favorable)
1.43
P/S (TTM) (<3 favorable)
1.32
P/B (<3 favorable)
4.60
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
3.34%
Institutions (25–75% balanced)
73.65%
Shares Outstanding
191,699,000
Float
172,427,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
192,510,000
Gross Profit (TTM)
107,983,000
EPS (TTM)
-0.10
Profit Margin (>10% good)
-0.10%
Operating Margin (TTM) (higher better)
-0.07%
ROE (TTM) (>15% strong)
-0.36%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.16
Momentum
Bearish momentum
Value
0.0031
Previous
-0.0009
Trend
Rising
Signal Cross
Crossed Up Today
As of
Sep. 05, 2025